Hanseatic Management Services’s Agios Pharmaceuticals AGIO Stock Holding History

Hanseatic Management Services’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-220	Closed	-$12K	–	179
2020 Q2	$12K	Hold	220	–	–	0.01%	140
2020 Q1	$8K	Buy	+220	New	+$10.2K	0.01%	161
2018 Q4	–	Sell	-8,432	Closed	-$650K	–	252
2018 Q3	$650K	Hold	8,432	–	–	0.61%	60
2018 Q2	$710K	Buy	+8,432	New	+$735K	0.61%	54
2017 Q1	–	Sell	-13,082	Closed	-$546K	–	396
2016 Q4	$546K	Buy	+13,082	New	+$686K	0.31%	127
2015 Q3	–	Sell	-9	Closed	-$1K	–	353
2015 Q2	$1K	Sell	9 -3,243	-100%	-$349K	﹤0.01%	324
2015 Q1	$307K	Buy	3,252 +2,901	+826%	+$325K	0.16%	147
2014 Q4	$39K	Buy	+351	New	+$31.3K	0.02%	180

Other funds holding AGIO

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hanseatic Management Services's AGIO Position: Q3 2020 in Review

Hanseatic Management Services sold out of Agios Pharmaceuticals (AGIO) in Q3 2020, closing a stake of 220 shares — an estimated $12K sold.

Hanseatic Management Services first reported a position in AGIO in Q4 2014 and held it in 8 quarters. The position peaked at $710K in Q2 2018. 215 funds tracked by Wall St. Rank hold AGIO as of Q3 2020.

Hanseatic Management Services reported no remaining Agios Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Hanseatic Management Services sold 220 Agios Pharmaceuticals shares in Q3 2020, an estimated $12K.
Hanseatic Management Services first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 8 quarters.
Hanseatic Management Services's Agios Pharmaceuticals position peaked at $710K in Q2 2018.
215 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2020.

Based on Hanseatic Management Services's 13F filing for Q3 2020, filed 29 Oct 2020.